SIMPLY BY SIMPLEX Trademark

Trademark Overview

On Thursday, December 16, 2021, a trademark application was filed for SIMPLY BY SIMPLEX with the United States Patent and Trademark Office. The USPTO has given the SIMPLY BY SIMPLEX trademark a serial number of 97175574. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, December 16, 2023. This trademark is owned by NARTEX LABORATORIOS HOMEOPÁTICOS, S.A. DE C.V.. The SIMPLY BY SIMPLEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of sleeplessness, restlessness, nervous tension and mental fatigue
simply by simplex

General Information

Serial Number97175574
Word MarkSIMPLY BY SIMPLEX
Filing DateThursday, December 16, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, December 16, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of sleeplessness, restlessness, nervous tension and mental fatigue

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 21, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNARTEX LABORATORIOS HOMEOPÁTICOS, S.A. DE C.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMunicipio Torreón Coahuila2
MX

Trademark Events

Event DateEvent Description
Monday, December 18, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Saturday, December 16, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Saturday, December 16, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, August 30, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 30, 2023NON-FINAL ACTION E-MAILED
Wednesday, August 30, 2023NON-FINAL ACTION WRITTEN
Tuesday, July 25, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 25, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 25, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 24, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 24, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, July 24, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 24, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 26, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 26, 2023NON-FINAL ACTION E-MAILED
Monday, June 26, 2023NON-FINAL ACTION WRITTEN
Thursday, June 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 30, 2023ASSIGNED TO LIE
Wednesday, February 15, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, February 2, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, February 2, 2023LETTER OF SUSPENSION E-MAILED
Thursday, February 2, 2023SUSPENSION LETTER WRITTEN
Thursday, January 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 25, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 25, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, September 24, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, September 24, 2022NON-FINAL ACTION E-MAILED
Saturday, September 24, 2022NON-FINAL ACTION WRITTEN
Thursday, September 22, 2022ASSIGNED TO EXAMINER
Tuesday, December 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 20, 2021NEW APPLICATION ENTERED

Related Keywords

simplex simply tension mental fatigue nervous restlessness preparations treatment sleeplessness pharmaceutical